|Scoping workshop:||25 March 2015|
|Consultation on draft scope with stakeholders:||15 April 2015 - 13 May 2015|
|Expected publication||31 October 2017|
|Developer||National Guideline Centre|
- If you have any queries please email firstname.lastname@example.org
|31 March 2017||The chronic asthma management guideline will publish in October 2017 alongside the asthma diagnosis and management guideline.|
|28 December 2016 - 16 February 2017||Draft guidance consultation|
|10 November 2016||Pre-consultation documents released|
|15 April 2016||Stakeholder list updated|
|07 July 2015||Committee meeting|
|31 July 2015||
The NCCs may make a focussed call for evidence on specific clinical questions or subquestions, after it has done initial searches. It will be able to make a call at any point during development of the guideline, and stakeholders will usually be given 4weeks to respond. The NCC will approach all registered stakeholders for this evidence. The NCC may not issue any calls for evidence for a guideline if the Guideline Development Group (GDG) feels it is not necessary. In addition, the NCCs will accept relevant confidential data for consideration by the GDG. The Health Economic plan, review questions and search strategies will be available on the website 5 weeks prior to consultation commencing.
|06 July 2015||
The Committee looks at the evidence and develops the recommendations in the guideline.
|15 May 2015||
Consultation on the draft scope is complete and the scope is being modified in the light of the comments. The final scope will be posted here. It will define what the guideline will cover.
We are in the finalising details for developing the guideline, including the membership of the Committee and timescales.
|15 April 2015||
The scope defines what the guideline will cover. We want to hear your views.
The Committee looks at the evidence and develops the recommendations in the guideline. We are looking for specialists in the topic, people working in health and social care more generally (such as GPs) and commissioners, and people using health and care services and/or carers or advocates, and people from communities affected by the guideline.
For more information see Developing NICE guidelines: how to get involved.
|31 October 2014||The referral was received from the Department of Health as part of the Institute's work programme.|
For further information on the guideline development process, please read how we develop NICE guidelines